News

AAOS Announces First Musculoskeletal Tumor Registry Report Results

AAOS Announces First Musculoskeletal Tumor Registry Report Results

AAOS Releases Groundbreaking Annual Report on Sarcoma Care

Transforming the future of musculoskeletal oncology through comprehensive data analysis

The American Academy of Orthopaedic Surgeons' (AAOS) Musculoskeletal Tumor Registry (MsTR) has launched its inaugural Annual Report, representing a significant step forward in the field of musculoskeletal oncology. This report serves as the first nationwide compilation of real-world clinical data, meticulously gathered from physicians treating patients with complex bone and soft-tissue tumors.

Reflecting the dedication of health professionals across multiple institutions, the 2025 report collates 1,189 surgical procedures recorded between 2016 and 2025. Impressively, the dataset has seen a remarkable 67% growth, emphasizing the increasing volume of data submissions year on year. These insights are crucial for enhancing the quality of care for patients diagnosed with sarcomas.

Unlocking Insights for Better Treatment Strategies

Dr. Benjamin J. Miller, chair of the MsTR Steering Committee, highlights the significance of this inaugural report: "This marks a pivotal moment for musculoskeletal oncology. With high-quality, provider-entered data at our disposal for the first time, we can better understand treatment patterns and identify gaps within our practices that must be addressed to advance patient care."

The report provides an extensive overview of patient demographics, tumor characteristics, treatment modalities, and outcomes associated with bone and soft-tissue sarcoma care. By establishing standard measures across various institutions, orthopaedic surgeons and researchers can effectively monitor variations in clinical practice and evaluate device performance.

Key Highlights of the 2025 Annual Report

Demographics and Treatment Patterns

  • The predominant age groups among patients are those aged between 60 to 79 years.
  • Notably, limb salvage procedures accounted for 91.1% of all surgical interventions, demonstrating the prevalent approach in current sarcoma treatments.

Tumor and Treatment Characteristics

  • The report reveals that soft-tissue sarcomas were more commonly documented than their bone sarcoma counterparts.
  • Most tumors classified within the data were observed to be grade G3, indicating a critical aspect of tumor pathology that requires attention.

Improving Care Coordination

  • Data showed that 68.9% of biopsies were conducted at the treating institution, with nearly one-third performed at referring entities. This presents an opportunity to simplify care pathways and enhance coordination among healthcare providers.

Insights into Device Usage

  • The report demonstrates enhanced analytic methods capturing vital information regarding implant usage, enabling deeper dives into treatment effectiveness, device safety, and ongoing quality improvement initiatives.

Patient Outcomes After Surgical Interventions

  • Encouragingly, almost 80% of patients were discharged either home or to a home-health facility post-surgery, underscoring successful surgical interventions.

Collaborative Efforts to Enhance Sarcoma Care

In partnership with the Musculoskeletal Tumor Society (MSTS), the MsTR aims to foster quality improvement and evidence-based decision-making in sarcoma management. The continued growth of participation in this registry will provide invaluable insights into treatment variability and the real-world effectiveness of care protocols. Such findings will ultimately assist the orthopaedic oncology community in delivering safer and more effective treatments for patients facing these challenging conditions.

About AAOS Registry Program

The mission of the AAOS Registry Program revolves around enhancing orthopaedic care through the accumulation, analysis, and reporting of significant clinical data. The flagship program, the American Joint Replacement Registry (AJRR), represents the largest national database of hip and knee joint replacement surgeries, encapsulating over 4.6 million procedures. Additional offerings of the registry program encompass several databases, promising continuous improvement in patient care through advanced analysis and knowledge sharing.

About the American Academy of Orthopaedic Surgeons

As the leading global association of musculoskeletal specialists, the American Academy of Orthopaedic Surgeons, with over 39,000 members, is committed to advancing the health of individuals through exceptional education and resources. AAOS is a trusted authority on musculoskeletal health, guiding improvements in patient treatment and ensuring that members stay at the forefront of orthopaedic practice.

Frequently Asked Questions

What is the Musculoskeletal Tumor Registry (MsTR)?

The MsTR is a national database collecting real-world clinical data to enhance care for sarcoma patients.

Why is the 2025 Annual Report significant?

This report is the first comprehensive analysis of national clinical data in musculoskeletal oncology, highlighting trends and treatment patterns.

What types of sarcomas are most commonly reported?

Soft-tissue sarcomas were more frequently reported than bone sarcomas according to the report.

How does the registry improve patient care?

The registry identifies treatment variations and provides insights that can lead to improved care pathways and outcomes.

What is the AAOS's role in sarcoma management?

AAOS provides education and resources that enhance the skills of orthopaedic surgeons to improve musculoskeletal health.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Epilepsy Campaign Puts Patient Voices Before Investors

Updated Category News Views 12

An epilepsy diagnosis can turn ordinary family routines into a maze overnight, which is why awareness work deserves more than the usual polite nod and a colored ribbon. Mediaplanet's national Epilepsy Awareness campaign, launched November 20, 2026, brings the subject into a USA TODAY print insert and related digital coverage during Epilepsy Awareness Month. That reach...

Continue Reading
Bybit Adds ANT, but Trading Access Has Real Fine Print

Updated Category News Views 27

Anthropic shares have landed on Bybit Stocks, and the headline is simple enough: eligible customers can trade ANT after the company’s public listing. But this is one of those announcements where the plumbing deserves as much attention as the shiny new ticker. A platform can make access feel effortless right up until a jurisdiction rule, a verification hurdle, or a...

Continue Reading
Sivers Moves Q3 Release to Accommodate U.S. Investors

Updated Category News Views 46

Thanksgiving has a nasty habit of turning perfectly ordinary earnings dates into ghost towns, and Sivers Semiconductors has sensibly stepped around that pothole. The company will publish its third-quarter 2026 interim report on Monday, November 30, rather than Thursday, November 26. That is not a strategy reset, a warning, or some grand corporate mystery. It is a calendar...

Continue Reading
Botanica’s Illuminations Carries More Than Holiday Glow

Updated Category News Views 106

Two million lights are doing more than brightening up a few winter evenings in Wichita. Illuminations at Botanica returns from November 23, 2026, through January 2, 2027, and the pleasant part of this story is that the spectacle has a practical backbone: it is Botanica’s largest fundraiser. For a garden nonprofit, that matters a whole lot more than another shiny...

Continue Reading
SeoulTech's Liver Chip Makes Toxicity Testing Practical

Updated Category News Views 32

A Lab Tool Finally Built for the Messy Part Thousands of everyday chemicals are floating around commerce with thin toxicity records, and that is a lousy way to run a modern economy. Seoul National University of Science and Technology researchers have put forward a modular liver-on-a-chip platform aimed squarely at that gap: making environmental chemical testing more...

Continue Reading
Blue Moon Closes Turner Deal, Eyes Nevada Mill Plan

Updated Category News Views 111

A shuttered Oregon copper-gold deposit just became part of Blue Moon’s puzzle, and the real question is whether the pieces can ever be made to fit cheaply enough to matter. Turner Adds a Nearby VMS Angle Blue Moon Metals has completed its acquisition of the Turner copper-gold deposit in O’Brien, Oregon, from Gold Coast Mining. The formal closing follows the September...

Continue Reading
PCS Rental Prep Is About Control Before Distance Hits

Updated Category News Views 82

A vacant house can turn into a long-distance headache with startling speed. For military homeowners preparing for a PCS move, the useful point in Rhonda Leahy's guidance is not glamorous: settle the boring operational stuff before the moving boxes, travel orders, and new-duty-station chaos swallow the calendar. Renting out a former home is not merely collecting enough...

Continue Reading
CATL Builds Türkiye Battery Service Muscle in Istanbul

Updated Category News Views 93

Battery warranties look mighty impressive until a pack needs work on a Tuesday morning and nobody nearby can touch it. CATL's new NING SERVICE Experience Center in Istanbul goes straight at that unglamorous problem. The facility, announced November 19, 2026, is described as Türkiye's first dedicated battery depot repair center and an integrated sales-and-service hub. It...

Continue Reading
PenFed’s Toys for Tots Drive Targets Holiday Gift Gaps

Updated Category News Views 116

A missing present under a tree is not a statistic anybody ought to glide past. PenFed Credit Union has opened its annual Toys for Tots collection across Washington-region branches, taking new, unwrapped toys through December 8 at 1:00 p.m. ET. The useful detail, and frankly the one worth remembering when people default to buying the easiest shiny thing on a shelf, is...

Continue Reading
TOP-REAL Tests Digital Monitoring in HER2 Cancer Care

Updated Category News Views 116

A cancer treatment can be extraordinarily potent and still get derailed by what happens on an ordinary Tuesday at home. That unglamorous gap between clinic visits is the whole point of TOP-REAL, a phase II academic study presented at ESMO AI & Digital Oncology 2026. Solti and its European partners are testing whether closer digital follow-up can catch trouble early enough...

Continue Reading

Top 5 Most Recently Viewed Articles

Datadog's Competitive Edge: Growth Through AI Innovations

Updated Category News Views 258

Understanding Datadog's Unique Position in the Market Datadog Inc. (NASDAQ: DDOG) is revolutionizing how businesses approach cloud-based security information and event management (SIEM) with its advanced observability platform. This platform aids developers, engineers, and IT departments in monitoring and optimizing their data and operational frameworks. By harnessing the...

Continue Reading
Important Updates on Venture Global Inc.'s Legal Proceedings

Updated Category News Views 251

Overview of the Class Action Against Venture Global, Inc. Venture Global, Inc. has recently come under scrutiny due to a class action lawsuit that caters to shareholders who purchased VG stock during the company's initial public offering (IPO). This legal action is a critical moment for those who have invested in the company, as the allegations pose significant...

Continue Reading
BioCity Biopharmaceutics Expands Cancer Treatment Options

Updated Category News Views 264

BioCity Biopharmaceutics Collaborates for Cancer Treatment BioCity Biopharmaceutics Co., Ltd., a forward-thinking biopharmaceutical company known for its innovative cancer treatment approaches, recently made a significant announcement regarding its clinical trial collaboration to explore the combination therapy of BC3195 and KEYTRUDA. This partnership aims to evaluate the...

Continue Reading
Kiromic BioPharma Reaches Resolution with SEC Over Investigation

Updated Category News Views 156

Kiromic BioPharma Settles SEC Investigation Kiromic BioPharma, Inc. (OTCQB: KRBP) has announced a pivotal resolution to an ongoing investigation by the U.S. Securities and Exchange Commission (SEC). This investigation stemmed from the company's previous executive management failing to disclose crucial details related to clinical holds on its investigational new drug (IND)...

Continue Reading
Daiso Expands into New California Markets with Store Openings

Updated Category News Views 885

Daiso Expands Its Presence in California Daiso, the renowned retail chain that boasts a variety of affordable, unique products, is excited to announce the opening of three new stores. These locations enhance Daiso's footprint in the marketplace, showcasing the company's commitment to serve more customers in innovative ways. New Store Openings The grand openings will take...

Continue Reading